Sequenom upgraded to Outperform from Market Perform at William Blair William Blair upgraded Sequenom (SQNM) to Outperform after its survey indicated a high likelihood of non-invasive prenatal testing moving quickly into the $1B-plus average-risk pregnancy market. The firm also believes Sequenom's agreement last week with Quest Diagnostics (DGX) provides added market coverage.
Quest to acquire MemorialCare's laboratory outreach service business Quest Diagnostics and MemorialCare Health System announced they have entered into a definitive agreement for Quest to acquire MemorialCare Health System's laboratory outreach service business. The transaction is expected to be neutral to earnings in 2015. Quest and MemorialCare Health System expect to complete the acquisition in August. Financial terms were not disclosed.